In the fast-paced world of life sciences—from novel drugs and generics to biosimilars and cosmetics—speed and precision are non-negotiable. Yet, for regulatory affairs teams, the global landscape often feels less like a clear pathway and more like an ever-shifting, complex maze. Traditional methods of pharma regulatory intelligence software are buckling under the pressure....